Probably safe to use if: sealed lyophilized vial at controlled room temperature for less than 1 week, brief reconstituted exposure under 2 hours, no visible changes, and peptide responds normally on initial test dose
Liu J, Ames BN (2005) Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimers disease, and Parkinsons disease
Tirzepatide Once Weekly for the Treatment of Obesity
doi: 10.3389/fphar.2023.1147414 Received 18 January 2023 Accepted 22 February 2023 Published 02 March 2023 Volume 14 - 2023 Edited by Zhihao Liu, Dalian Medical University, China Reviewed by Ral Gonzalez Ojeda, University of Galway, Ireland Hang Liu, University of California, Los Angeles, United States Updates Copyright 2023 Pei, Pan, Wei and Hua